 |
|
Predictive factors for early response to methimazole in children and adolescents with Graves disease: a single-institute study between 1993 and 2013
Sun Mi Hwang, Min Sun Kim, Dae-Yeol Lee
Ann Pediatr Endocrinol Metab. 2016;21(2):70-74. Published online 2016 Jun 30 DOI: https://doi.org/10.6065/apem.2016.21.2.70
|
|
Citations to this article as recorded by
 Long-Term Antithyroid Drug Treatment of Graves’ Disease in Children and Adolescents: A 20-Year Single-Center Experience
Ari Song, Su Jin Kim, Min-Sun Kim, Jiyeon Kim, Insung Kim, Ga Young Bae, Eunseop Seo, Young Seok Cho, Joon Young Choi, Sung Yoon Cho, Dong-Kyu Jin
Frontiers in Endocrinology.2021;[Epub] CrossRef Long-term outcomes of Graves’ disease in children and adolescents receiving antithyroid drugs
Jung Gi Rho, Change Dae Kum, Young Jun Seo, Young Suk Shim, Hae Sang Lee, Jin Soon Hwang
Annals of Pediatric Endocrinology & Metabolism.2021; 26(4): 266. CrossRef Long-Term Antithyroid Treatment in Pediatric and Juvenile Graves’ Disease
Hossein Delshad, Miralireza Takyar
International Journal of Endocrinology and Metabolism.2020;[Epub] CrossRef Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy
Yun Mi Choi, Mi Kyung Kwak, Sang Mo Hong, Eun-Gyoung Hong
Endocrinology and Metabolism.2019; 34(3): 268. CrossRef
|